Cover image not available

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications : a systematic review and economic

Publication Data

Title Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications : a systematic review and economic
Contributors Y-F. Chen, NIHR Evaluation, Trials and Studies Coordinating Centre, NIHR Health Technology Assessment Programme
Publisher Prepress Projects Ltd. on behalf of NETSCC, HTA.
Publication date 2009
Publication location Perth
Language English

Topics

Pulmonary hypertension :: Chemotherapy :: Cost-effectiveness
Clinical trials :: Great Britain

Catalogue Data

OBNB ID GBB005627
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.24

ISBD

P1053 xiv, 320 p.
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications : a systematic review and economic . Published by Prepress Projects Ltd. on behalf of NETSCC, HTA. in 2009. Publication and catalogue information, links to buy online and reader comments.